Beyond Achondroplasia

Growing together with Clara

May 14, 2017
by inesp.alves

BioCentury published the article “Competing for growth”

BioCentury´s Senior writer Mike Leviten wrote a substantial article about the current medicines in research and development for achondroplasia. The article was published on the 7th April. This competition between pharma companies is very positive since it stimulates industry to … Continue reading

August 25, 2015
by inesp.alves

B-701 – New potential treatment for achondroplasia

The motto of BioClin Therapeutics is “Developing protein therapeutics for high unmet medical needs”. And this has a deep meaning for achondroplasia. BioClin is a privately held biotechnology company funded in 2010, in California. Their leading product is B-701, that is … Continue reading

Translate »